Multus Biotechnology is a global leader in cell culture media design, helping biomanufacturing companies shorten their time to market while improving supply chain security.
By combining high-throughput robotic automation and ML, Multus revolutionizes cell culture media development - delivering breakthrough performance and efficiency that were previously unattainable.
Multus’ experienced, multi-disciplinary team of scientists and engineers is redefining the future of biomanufacturing. Harnessing the power of biology, automation, and machine learning, we accelerate the creation of high-performance, resource-efficient cell culture media, empowering the global bioeconomy and enabling the next generation of essential therapies, food, and materials.
Company Details
- Employees
- 27
- Founded
- -
- Address
- London, London W12, Gb
- in****@****s.media
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- multus.media
- Keywords
- Biotechnology, cellularagriculture, culturemedium, culturedmeat, cleanmeat, syntheticbiology, foodtech, bioengineering, geneticengineering, moonshot, bioeconomy, biopharma, celltherapies.
- HQ
- London, London
Multus Questions
Multus's website is multus.media
Multus's LinkedIn profile is https://uk.linkedin.com/company/multus-media
Multus has
27 employees.
View email and phone details for 27
employees at Multus.
Multus's industry is
Biotechnology Research
Multus's top competitors are
Labgenius Therapeutics,
Alchemab Therapeutics Ltd,
Quell Therapeutics,
Exogene,
Assuredrop,
Extracellular,
Promatix Biosciences Ltd,
Hoxton Farms,
Altos Labs,
Basecamp Research.
Multus's support email address is info@multus.media
Multus's categories are Biotechnology Research
Multus's founding year is 2020
